A novel approach to cancer immunotherapy — strategies designed to induce the immune system to attack cancer cells — may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
Researchers at the Broad Institute and Massachusetts General Hospital, both Harvard affiliates, have identified mutations in a gene that can reduce the risk of individuals developing type 2 diabetes. If a drug can be developed that mimics the protective effect of these mutations, it could open up new ways of preventing this devastating disease.
The first clinical trial of a drug intended to delay the onset of symptoms of Huntington’s disease (HD) reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants. Neuroimaging also showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic HD.
Syrian refugees struggling in Lebanon are on the edge of catastrophe, according to a new report from the FXB Center for Health and Human Rights.
Harvard’s Wyss Institute has found a new DNA-based, super-resolution microscopy method that could simultaneously spot dozens of distinct types of biomolecules. This could potentially lead to new ways to diagnose disease, track its prognosis, or monitor the effectiveness of therapies at a cellular level.
Remnants of Neanderthal DNA in modern humans are associated with genes affecting type 2 diabetes, Crohn’s disease, lupus, biliary cirrhosis, and smoking behavior. They also concentrate in genes that influence skin and hair characteristics. At the same time, Neanderthal DNA is conspicuously low in regions of the X chromosome and testes-specific genes.
Researchers have created embryonic stem cells without an embryo. This discovery of a novel reprogramming method of adult cells, without introducing external genetic material, could dramatically shift stem cell research.
A group of Harvard Medical School students is using the viral success of tongue-in-cheek video on the spleen to promote science education, launching a contest for younger students to make organ-themed music videos.
The waterproof, light-activated glue developed by researchers at Harvard-affiliated Brigham and Women’s Hospital and Children’s Hospital Boston and their colleagues at MIT can successfully secure biodegradable patches to seal holes in a beating heart.
Using color-coded labels to mark healthier foods and then displaying them more prominently appears to have prompted customers to make more healthful long-term dining choices in their large hospital cafeteria, according to a report from Harvard-affiliated Massachusetts General Hospital
Ludwig Cancer Research, on behalf of its founder, Daniel K. Ludwig, has given Harvard Medical School $90 million to spur innovative scientific inquiry and discovery. According to the Ludwig announcement, this new financial support is among the largest private gifts ever for cancer research.
The healthiest diets cost about $1.50 more per day than the least healthy diets, according to new research from Harvard School of Public Health. The finding is based on the most comprehensive examination to date comparing prices of healthy foods and diet patterns against less healthy ones.
The annual “Giving Thanks” open house was an opportunity for members of the Harvard community to write notes of gratitude to fellow staff members and provide support for community programs.
A Massachusetts General Hospital-led research team of Harvard affiliates has identified an immune cell protein that is critical to setting off the body’s initial response against viral infection.
In the largest study of its kind, people who ate a daily handful of nuts were found to be 20 percent less likely to die from any cause over a 30-year period than those who didn’t consume nuts, say Harvard researchers.
A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure.
What’s behind the fascination with horror? A number of Harvard experts recently offered their insight into the genre’s powerful lure.
Two new books from Harvard Health Publications are aimed at people who have more than normal levels of anxiety and depression but fall short of clinical definitions.
A Harvard-backed initiative in Chile aims to reduce economic disparity through an early education health initiative supported by the Harvard Graduate School of Education and Harvard Medical School.
Experts in child health gathered at Harvard Medical School on Tuesday for a symposium on how genome biology is changing children’s health.
Targeted nanotherapy is the wave of the medical future, according to Omid Farokhzad, a Harvard Medical School and Brigham and Women’s Hospital researcher who has two nanoparticle-based therapies in clinical trials and a slew of ideas for new ways to put the tiny capsules to work for human health.
James E. Rothman, a 1976 Harvard alumnus, won a share of the 2013 Nobel Prize in physiology or medicine for work illuminating the internal machinery that cells use to transport molecules.
From the calming and relaxing properties of lavender, to the antiviral offerings of lemon balm the Harvard Countway Community Garden offers a wealth of ...
People who are married when diagnosed with cancer live longer than those who are not married. Married patients also tended to have cancers diagnosed at an earlier stage, according to Harvard researchers.
After the U.S. Centers for Disease Control and Prevention issued a report on the threat from drug-resistant bacteria, David Hooper, a physician at Massachusetts General Hospital and an authority on the subject, discussed the issues during a question-and-answer session.
Professor Howard Green stumbled across a skin transplant technique that involved growing keratinocytes into full skin layers, making him a pioneer in regenerative medicine.
Removing a woman’s healthy breasts might seem like a radical response to fears of breast cancer. But for women with genetic mutations that put them at high risk of developing the disease, it’s a step that can cut their vulnerability by 90 to 95 percent.
A team of researchers at the Wyss Institute has found a way to self-assemble complex structures out of gel “bricks” smaller than a grain of salt. The new method could help solve one of the major challenges in tissue engineering.
Jessica Meir, an assistant professor of anesthesia at Harvard Medical School and Massachusetts General Hospital, is the latest member of the Harvard community given a chance to head to space, joining moon-walkers and Hubble Space Telescope repairmen as she trains to become a NASA astronaut.
A cross-disciplinary team of Harvard scientists, engineers, and clinicians announced Sept. 6 that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.
Thirty-one schoolteachers spent four days on campus last week at a workshop put together by Harvard’s regional centers and programs to provide background on the growing global water crisis.
An international scientific collaborative led by the Harvard Stem Cell Institute’s Kornelia Polyak has discovered why women who give birth in their early 20s are less likely to develop breast cancer than women who don’t, triggering a search for a way to confer this protective state on all women.
Scientists at Harvard-affiliated Dana-Farber Cancer Institute observed a strong and selective immune response in some patients who received several doses of a “personalized” tumor vaccine composed of their own inactivated leukemia cells combined with an immune stimulant.
About half of a small group of patients with fibromyalgia — a common syndrome that causes chronic pain and other symptoms — were found to have damage to nerve fibers in their skin and other evidence of a disease called small-fiber polyneuropathy.
The Nikon Imaging Center at Harvard Medical School is the largest light microscopy facility on the Longwood campus. The staff are busy transitioning the ...
Sixty men and women from across Harvard were honored for their outstanding work and service to the University’s mission at the annual Harvard Heroes event.
Specialists examines the country's obesity problem from several angles at an HMS-MGH forum.
H. Stephen Leff, an assistant professor of clinical psychology in the Department of Psychiatry at Harvard Medical School, has received the Carl Taube Award from the American Public Health Association.
Tucker Collins was S. Burt Wolbach Professor of Pathology and the Chief of Pathology at Boston Children’s Hospital. He passed away in 2007 at the age of 54 years due to an aggressive brain tumor.
Nothing about Joseph L. Henry was ordinary. In his academic career he excelled noticeably above others -- as a student, teacher, department chair, dean, board member, national policy adviser, and as a mentor to many health professionals and policy makers.
Fritz Heinz Bach, a brilliant transplant immunologist and the Lewis Thomas Distinguished Professor of Surgery at Harvard Medical School died of a cardiac arrest on Sunday, August 14, 2011 at his home at Manchester-by-the-Sea, Massachusetts. He was 77 years old.
Roger William Jeanloz, Professor of Biological Chemistry and Molecular Pharmacology emeritus at Harvard Medical School, died shortly before his 90th birthday on September 28, 2007, in the south of France where he was on holiday with his wife, Dorothea.
Dr. Mary Ellen Avery died on December 4, 2011 at the age of 84. She was best known to the world for her ground breaking research on the cause of hyaline membrane disease (later called Respiratory Distress Syndrome), an illness that claimed the lives of an estimated 10,000 infants in the United States each year. That discovery catapulted her to leadership positions in the United States and Canada and to the highest honors offered by national societies.
Dr. Mary Ellen Wohl, known internationally for her research in pediatric pulmonary diseases, passed away at age 77 in October, 2010 at Rogerson House in Jamaica Plain. Professor of Pediatrics at Harvard Medical School, she had served as Chief of the Division of Respiratory Diseases at Children’s Hospital Boston for 22 years and Director of its Cystic Fibrosis Center for 19 years, saving and touching countless lives along the way.
Benedict Nwachukwu, graduating with a dual M.D./M.B.A. degree, wants to apply the management skills he learned at Harvard Business School to the medical problems he finds in orthopedics and in global health.
MatriTarg Laboratories, a venture created by a team of Harvard fellows seeking new ways to diagnose and treat solid organ fibrosis, claimed the grand prize in the inaugural Deans’ Health and Life Sciences Challenge.
Dan W. Brock of Harvard Medical School on Wednesday delivered the 63rd George W. Gay Lecture in Medical Ethics at the School, focusing on population bioethics.
It turns out bike-friendliness is second nature for Harvard University. Weeks after being named a Silver-Level Bike Friendly University by the League of ...
Researchers from Harvard-affiliated Brigham and Women’s Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors.
For the first time, students at Harvard Medical School in the Longwood area are participating in the annual Arts First festival, the University’s four-day celebration of the visual, literary, and performing arts.